TNFRSF13B Gene Immunodeficiency common variable type 2 Genetic Test
At DNA Labs UAE, we offer the TNFRSF13B Gene Immunodeficiency common variable type 2 Genetic Test for individuals who suspect they may have common variable immunodeficiency type 2 (CVID2). This test can help diagnose CVID2 and provide valuable information for genetic counseling and treatment decisions.
Test Components and Price
- Test Name: TNFRSF13B Gene Immunodeficiency common variable type 2 Genetic Test
- Price: 4400.0 AED
Sample Condition and Report Delivery
- Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card
- Report Delivery: 3 to 4 Weeks
Method and Test Type
- Method: NGS Technology (Next-Generation Sequencing)
- Test Type: Osteology Dermatology Immunology Disorders
Doctor and Test Department
- Doctor: Dermatologist
- Test Department: Genetics
Pre Test Information
Before undergoing the TNFRSF13B Gene Immunodeficiency common variable type 2 Genetic Test, it is important to provide the clinical history of the patient. Additionally, a genetic counseling session will be conducted to draw a pedigree chart of family members affected with TNFRSF13B Gene Immunodeficiency common variable type 2 NGS Genetic DNA Test gene TNFRSF13B.
Test Details
The TNFRSF13B gene is associated with a type of immunodeficiency called common variable immunodeficiency type 2 (CVID2). CVID2 is a primary immunodeficiency disorder characterized by low levels of antibodies and recurrent infections.
NGS (Next-Generation Sequencing) genetic testing is a method used to analyze the DNA sequence of genes. In the context of CVID2, NGS genetic testing can be used to identify mutations or variations in the TNFRSF13B gene that may be causing the immunodeficiency.
By identifying specific genetic variants in the TNFRSF13B gene, NGS genetic testing can help diagnose CVID2 and provide valuable information for genetic counseling and treatment decisions. It can also help identify other family members who may be at risk of developing the condition.
It is important to note that NGS genetic testing is just one tool used in the diagnosis and management of CVID2. Other clinical and laboratory tests may also be necessary to confirm the diagnosis and guide treatment.
Test Name | TNFRSF13B Gene Immunodeficiency common variable type 2 Genetic Test |
---|---|
Components | |
Price | 4400.0 AED |
Sample Condition | Blood or Extracted DNA or One drop Blood on FTA Card |
Report Delivery | 3 to 4 Weeks |
Method | NGS Technology |
Test type | Osteology Dermatology Immunology Disorders |
Doctor | Dermatologist |
Test Department: | Genetics |
Pre Test Information | Clinical History of Patient who is going for TNFRSF13B Gene Immunodeficiency common variable type 2 NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with TNFRSF13B Gene Immunodeficiency common variable type 2 NGS Genetic DNA Test gene TNFRSF13B |
Test Details |
The TNFRSF13B gene is associated with a type of immunodeficiency called common variable immunodeficiency type 2 (CVID2). CVID2 is a primary immunodeficiency disorder characterized by low levels of antibodies and recurrent infections. NGS (Next-Generation Sequencing) genetic testing is a method used to analyze the DNA sequence of genes. In the context of CVID2, NGS genetic testing can be used to identify mutations or variations in the TNFRSF13B gene that may be causing the immunodeficiency. By identifying specific genetic variants in the TNFRSF13B gene, NGS genetic testing can help diagnose CVID2 and provide valuable information for genetic counseling and treatment decisions. It can also help identify other family members who may be at risk of developing the condition. It is important to note that NGS genetic testing is just one tool used in the diagnosis and management of CVID2. Other clinical and laboratory tests may also be necessary to confirm the diagnosis and guide treatment. |